Allows for Commercial Deployment of the Company's Radiation-Free Breast Imaging Technology Under Distribution Agreement with Al Naghi Medical Co., Supports $24 Million Revenue Pipeline Through 2028

QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its Breast Acoustic CT™ scanner has received official classification and clearance from the United Arab Emirates (UAE) Emirates Drug Establishment (EDE) for use as a medical device in that country.

This clearance allows for the importation and distribution of our scanner through EDE-licensed medical warehouses, ensuring compliance with UAE healthcare infrastructure standards and enabling marketing to licensed healthcare facilities across the country. It also represents a significant step in QT Imaging's global strategy and reinforces its commitment to expanding access to advanced compression-free, 3D technology offering a more comfortable and radiation-free alternative for breast imaging.

In January 2026, QT Imaging signed an exclusive distribution agreement with Al Naghi Medical Co., a leading provider of medical devices in the UAE, for the QTI scanner and the QTI Cloud Platform, establishing a $24 million revenue pipeline through 2028. According to national data cited by Elobaid et al.1, breast cancer accounts for 25% of all cancer cases in the UAE and 43% of cancers among women, underscoring the urgent need for safe and effective breast imaging solutions.